Feedback / Questions
inobrodib (CCS1477) - CellCentric
https://www.businesswire.com/news/home/20260506542056/en/CellCentric-Announces-Oversubscribed-%24220-Million-Series-D-Financing-to-Advance-Pivotal-Trials-of-Inobrodib-in-Multiple-Myeloma
May 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next